Network Connectivity and Temporal Processing in Adolescents Who Stutter

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jan 31, 2027 → Jan 31, 2028
See other at-risk trials from University of Michigan

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jan 31, 2027 to Jan 31, 2028
    • Primary endpoints: details revised at 3 of 3 entries
    • Eligibility criteria expanded, about 15 words
  2. Primary and study completion dates: Jan 31, 2026 to Jan 31, 2027
    • Site contact updated
    v9
  3. Primary and study completion dates: Jan 2026 to Jan 31, 2026
    • Site contact updated
    v8
  4. Primary and study completion dates: Jan 2025 to Jan 2026v7
  5. Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date changed from estimate of Jul 2022 to Jul 23, 2022v5
  2. Start date: Jun 2022 to Jul 2022v4
  3. Start date: Apr 2022 to Jun 2022v3
  4. Start date: Mar 2022 to Apr 2022v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The specific purpose of this clinical trial is to compare performance on rhythm perception and production tasks between children who stutter and children who do not stutter. The overall project also aims to investigate how performance on rhythm tasks may be related to brain activity (non-clinical trial).
Trial Details
NCT Number NCT05286151
Lead Sponsor University of Michigan
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions
(from sponsor)		 Stuttering, Childhood, Stuttering
Related terms Speech Disorders, Stuttering
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov